Long-term efficacy and safety of cannabidiol in patients with treatment-resistant focal epilepsies treated in the Expanded Access Program. Epilepsia.Issue #Epilepsia. 2025;00:1–11., 2025
- Author:Patel AD, Szaflarski JP, Lyons PD, Boffa M, Greco T, Saurer TB, et al.
View Publication
Vagus nerve stimulation in Lennox–Gastaut syndrome: Twenty-four-month data and experience from the CORE-VNS studyIssue #Epilepsia, 2025
- Author:Lyons P, Wheless J, Verner R, Ferreira J, Liow K, Valeriano J, et al.
- Publisher:Epilepsia
View Publication
Efficacy of cannabidiol in convulsive and nonconvulsive seizure types associated with treatment-resistant epilepsies in the Expanded Access Program
- Author:Paul D. Lyons, Robert J. Flamini, Anne M. Comi, E. Martina Bebin, Michael G. Chez, Gary Clark, Orrin Devinsky, Shaun A. Hussain, Anup D. Patel, Jillian L. Rosengard, Farhad Sahebkar, Eric Segal, Laurie Seltzer, Jerzy P. Szaflarski, Arie Weinstock
- Publisher:Epilepsia
